🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates safety and tolerability of a single ascending dose of ...
Status
Completed
Location
Children's Hospital of Philadelphia
Start Date
2017-08-24
Trial ID
NCT03096080
Treatments Being Tested
Evaluate the safety and tolerability and determine the maximum tolerated do...
Status
Terminated
Location
UC San Diego Moores Cancer Center
Start Date
2014-05
Trial ID
NCT02154529
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of the m...
Status
Completed
Location
Stanford University Medical Center
Start Date
2006-07
Trial ID
NCT00336765
Treatments Being Tested
The purpose of this study is to determine the best confirmed response rate ...
Status
Completed
Location
Ronald Yanagihara
Start Date
2007-05
Trial ID
NCT00522145
Treatments Being Tested
The primary objective of this study Phase 1b was to determine the safety, p...
Status
Completed
Location
UCLA Medical Center
Start Date
2012-10-11
Trial ID
NCT01559363
Treatments Being Tested
The goal of the study was to compare and evaluate safety and efficacy of te...
Status
Completed
Location
University of California San Diego
Start Date
2017-10-12
Trial ID
NCT03203642
Treatments Being Tested
The purpose of this phase II study is to determine the safety, tolerability...
Status
Completed
Location
Hematology Oncology Associates of the Treasure Coast
Start Date
2006-07
Trial ID
NCT00364780
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, and hig...
Status
Withdrawn
Location
Memorial Sloan Kettering Cancer Center
Start Date
2008-06
Trial ID
NCT00704392
Subjects who received tesevatinib in Study KD019-101 and completed 24 month...
Status
Terminated
Location
UCLA Medical Center
Start Date
2015-12-25
Trial ID
NCT02616055
Treatments Being Tested
The primary objective of this study is as follows: * To evaluate the safet...
Status
Completed
Location
Stanford University Medical Center
Start Date
2004-06
Trial ID
NCT00086528
Treatments Being Tested